Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
90.61
-2.37 (-2.55%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biontech Se ADR
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
53
54
Next >
Why Is Moderna (MRNA) Stock Down 5% Today?
February 17, 2023
If Moderna's new formulation works the latest failure will be a short-term hiccup. But MRNA stock also faces legal and PR challenges.
Via
InvestorPlace
Pfizer/BioNTech Get Ready For London Court Battle With Moderna Over COVID-19 Vaccine Patents
February 17, 2023
Via
Benzinga
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
The landscape has shifted dramatically in the COVID-19 vaccine market.
Via
The Motley Fool
The 3 Most Undervalued Growth Stocks for Your February Buy List
February 06, 2023
These undervalued growth stocks have the value and projected growth that investors seek when researching their next investment decisions.
Via
InvestorPlace
Better Buy: Novavax or BioNTech Stock?
February 04, 2023
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Via
The Motley Fool
The 7 Most Undervalued Biotech Stocks to Buy in February 2023
February 02, 2023
Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.
Via
InvestorPlace
Analyst Ratings for BioNTech
January 24, 2023
Via
Benzinga
BioNTech Starts Dosing In Herpes Vaccine Candidate Study
December 21, 2022
Via
Benzinga
Will Investors Notice Exciting Sign On BioNTech's Chart?
December 19, 2022
Via
Benzinga
Why BioNTech And Moderna Shares Are Falling After Pfizer News
January 31, 2023
BioNTech SE - ADR (NASDAQ: BNTX) and Moderna Inc (NASDAQ: MRNA) shares are trading lower Tuesday morning in sympathy with Pfizer Inc. (NYSE:
Via
Benzinga
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.
Via
Benzinga
Novavax Jumps After Pledging To Update Its Covid Shot; Pfizer, Moderna Slip
January 27, 2023
The FDA's experts voted in favor of annual boosters on Thursday.
Via
Investor's Business Daily
Thursday Predictions: 3 Hot Stocks for Tomorrow
January 25, 2023
Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why.
Via
InvestorPlace
COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today
January 23, 2023
The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19.
Via
Benzinga
Google Layoffs 12K Employees, Netflix's Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly's Alzheimer's Candidate: Top Stories Friday, Jan. 20
January 20, 2023
Here's a round-up of stories from around the globe and from various media outlets. Benzinga
Via
Benzinga
Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots
January 20, 2023
Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).
Via
Benzinga
Pfizer (PFE) Stock Falls on Analyst Downgrade
January 17, 2023
Although Pfizer led the charge in forwarding Covid-19 solutions, possibly waning relevancy poses serious concerns for PFE stock.
Via
InvestorPlace
Pfizer Stock Dives As Analyst Calls For 'Covid Reset' And Downgrades Shares
January 17, 2023
Shares have skidded almost 10% in the first two weeks of 2023.
Via
Investor's Business Daily
US Health Agencies Investigate Preliminary COVID-19 Vaccine Safety Signal In Older People
January 16, 2023
The U.S.
Via
Benzinga
Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot
January 13, 2023
Johnson & Johnson (NYSE: JNJ) has significantly scaled back its efforts of manufacturing its COVID-19 vaccine after facing a fall in demand.
Via
Benzinga
Nice Gains During JPM23 Week: Benign CPI Report Brings Hope For A “Soft Landing”
January 12, 2023
Small-cap speculative biotech stocks regain interest with volatility.
Via
Talk Markets
BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup
January 10, 2023
Via
Benzinga
Israel Based Study Shows Omicron Adapted Vaccine Shots Cut Hospitalization Rates In Elderly
January 09, 2023
Israel based real-world study shows that omicron-targeted COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) reduced hospitalizations among older patients.
Via
Benzinga
CRISPR, Genetics And AI — Why 2023 Could Be The Year For Biotech Stocks
January 06, 2023
Genetic medicine is a top theme now for biotech stocks. Other trends are heating up too.
Via
Investor's Business Daily
2 Top Biotech Stocks to Buy Right Now
January 06, 2023
These two pharmaceutical companies pay market-beating dividends to shareholders.
Via
The Motley Fool
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
January 03, 2023
Via
Benzinga
Why BioNTech Was a Sickly Stock This Week
December 30, 2022
The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks.
Via
The Motley Fool
Three Pharma Stocks to Sell Before They Die
December 24, 2022
As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January.
Via
InvestorPlace
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
December 18, 2022
These seven hottest healthcare stocks have strong growth catalysts that could send each of them higher over the next few years.
Via
InvestorPlace
Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review
December 16, 2022
Moderna spiked on a cancer vaccine while Tesla continued to dive.
Via
Investor's Business Daily
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
53
54
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.